Brent Bush, CFO of a medical device distributor, BioTron Medical, Inc., was approached by a Japanese customer, Numata, with a proposal to pay cash (in yen) for its typical orders of 13,300,000 every other month if it were given a 4.7% discount. Numata's current terms are 30 days with no discounts. Using the quotes and estimated cost of capital for BioTron Medical in the popup window, Bush will compare the proposal with covering yen payments with forward contracts. Should Brent Bush accept Numata's proposal? Assume a 360-day financial year.

CHART:

Spot rate: 110.73/$

30-day forward rate: 109.93/$

90-day forward rate: 109.33/$

180-day forward rate: 108.73/$

Numata's WACC 8.82%

BioTron's WACC 9.43%